Search IPOs
ACCRETION
Accretion Nutraveda IPO, a SME IPO was listed on the exchange on February 4, 2026. The price band is set between ₹122 –129 , with a face value of ₹10 . Retail investors can apply with a minimum of 2 lots, each comprising 1,000 shares — amounting to ₹258,000 at the upper price.
Accretion Nutraveda IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.
Accretion Nutraveda IPO SME Important Dates
Get important updates regarding Accretion Nutraveda IPO SME tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.
Issue price ₹129
Issue
₹129
Open Date
Jan 28
Close Date
Jan 30
Allotment
Feb 02
Listing
Feb 04
Issue Size
1,920,000 shares
(aggregating up to ₹25.00 Cr)
Issue Price
₹122 – ₹129
Face Value
₹10/share
Market Lot
1,000 shares
Retail Min Investment
₹258,000
Listing At
BSE
Sale Type
fresh issue
Fresh Issue
1,824,000 shares
(aggregating up to ₹24 Cr)
Reserved for Market Maker
96,000 shares
(aggregating up to ₹1.24 Cr)
Issue Type
book building
Last updated: 1 month ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 04 Feb 2026 Latest | ₹129 | ₹68 | ₹197 | ₹68 |
52.71%
|
12:07 PM |
| 03 Feb 2026 | ₹129 | ₹68 | ₹197 | ₹68 |
52.71%
|
2:45 PM |
| 02 Feb 2026 | ₹129 | ₹17 | ₹146 | ₹17 |
13.18%
|
2:17 PM |
| 01 Feb 2026 | ₹129 | ₹6 | ₹135 | ₹6 |
4.65%
|
9:26 PM |
| 31 Jan 2026 | ₹129 | ₹6 | ₹135 | ₹6 |
4.65%
|
2:58 PM |
| 30 Jan 2026 | ₹129 | ₹4 | ₹133 | ₹4 |
3.1%
|
3:09 PM |
| 29 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
5:26 PM |
| 28 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
4:40 PM |
| 27 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
4:56 PM |
| 26 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
2:57 PM |
| 25 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
4:09 PM |
| 24 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
6:47 PM |
| 23 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
2:21 PM |
| 22 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
6:53 PM |
| 21 Jan 2026 | ₹129 | ₹0 | ₹129 | ₹0 |
0%
|
4:53 PM |
Latest snapshot: Jan 30, 2026
| Category | Subscribed (x) | No. of Applications |
|---|---|---|
| QIB | 1.01x | — |
| NII | 2.08x | — |
| bNII (bids above ₹10L) | 1.95x | — |
| sNII (bids below ₹10L) | 2.33x | — |
| Retail Investors | 2.19x | — |
| Total | 1.83x | — |
Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel are the company promoters.
IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹258,000 |
| Retail (Max) | 1 | 1,000 | ₹129,000 |
| S-HNI (Min) | 3 | 3,000 | ₹387,000 |
| S-HNI (Max) | 7 | 7,000 | ₹903,000 |
| B-HNI (Min) | 8 | 8,000 | ₹1,032,000 |
The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 908,000 (47.29%) |
|
•
Anchor Investor Shares Offered
|
546,000 (28.44%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
362,000 (18.85%) |
| NII (HNI) Shares Offered | 276,000 (14.37%) |
|
•
bNII > ₹10L
|
184,000 (9.58%) |
|
•
sNII < ₹10L
|
92,000 (4.79%) |
| Retail Shares Offered | 640,000 (33.33%) |
| Market Maker Shares Offered | 96,000 (5.00%) |
| Total Shares Offered | 1,920,000 (99.99%) |
Accretion Nutraveda Limited is an Ahmedabad-based healthcare-focused CDMO. The company specializes in the manufacturing of a diverse range of Ayurvedic and nutraceutical products including tablets, capsules, oral liquids, oral powders, external preparations, and oils. Its portfolio covers various healthcare segments such as bone and joint care, respiratory care, cardiac care, skin and hair care, and baby care.
Key Strengths:
Growth:
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 Latest |
|---|---|---|---|
| Total Revenue | 3.07 | 5.2 |
16.06
↑ 208.8%
|
| Profit After Tax (PAT) | 0.28 | 0.82 |
2.61
↑ 218.3%
|
| EBITDA | 0.59 | 1.21 |
3.65
↑ 201.7%
|
| Total Assets | 4.06 | 4.64 |
10.86
↑ 134.1%
|
| Net Worth | 0.26 | 1.08 |
5.35
↑ 395.4%
|
| Reserves & Surplus | -0.1 | 0.72 |
4.86
↑ 575.0%
|
| Total Borrowing | 1.97 | 2.17 |
3.86
↑ 77.9%
|
Revenue & Profit Trend
The Accretion Nutraveda IPO is expected to open in January, 2026, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Accretion Nutraveda IPO is ₹122.00 - ₹129.00 per share.
As per market sources, Accretion Nutraveda IPO GMP is currently ₹68.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Accretion Nutraveda IPO stands at 1.83x overall.
The listing date for Accretion Nutraveda IPO is February 4, 2026.
No comments yet. Be the first to comment!
